Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Imondi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|June 1, 1984
Myocardial effects of mitoxantrone and doxorubicin in the mouse and guinea pigW E Perkins, R L Schroeder, R A Carrano, et al.
British Journal of Cancer|October 1, 1982
Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pigW E Perkins, R L Schroeder, R A Carrano, et al.
Journal of Pharmaceutical Sciences|November 1, 1982
Isolation, identification, and synthesis of the major sulpiride metabolite in primatesJ J Brennan, A R Imondi, D G Westmoreland, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1978
Metabolism of sulpiride in man and rhesus monkeysA R Imondi, A S Alam, J J Brennan, et al.
Veterinary and Comparative Oncology|April 22, 2009
Intravenous administration of 9-aminocamptothecin to dogs with lymphomaA S Moore, A R Imondi, P L de Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancerP L de Souza, M R Cooper, A R Imondi, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxaneP Della Torre, G Mazué, A Podestà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Development of inhalational agents for oncologic useS Sharma, D White, A R Imondi, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxelP Della Torre, A R Imondi, C Bernardi, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potentialP Della Torre, A Podestà, A R Imondi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|June 1, 1984
Myocardial effects of mitoxantrone and doxorubicin in the mouse and guinea pigW E Perkins, R L Schroeder, R A Carrano, et al.
British Journal of Cancer|October 1, 1982
Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pigW E Perkins, R L Schroeder, R A Carrano, et al.
Journal of Pharmaceutical Sciences|November 1, 1982
Isolation, identification, and synthesis of the major sulpiride metabolite in primatesJ J Brennan, A R Imondi, D G Westmoreland, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1978
Metabolism of sulpiride in man and rhesus monkeysA R Imondi, A S Alam, J J Brennan, et al.
Veterinary and Comparative Oncology|April 22, 2009
Intravenous administration of 9-aminocamptothecin to dogs with lymphomaA S Moore, A R Imondi, P L de Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancerP L de Souza, M R Cooper, A R Imondi, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxaneP Della Torre, G Mazué, A Podestà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Development of inhalational agents for oncologic useS Sharma, D White, A R Imondi, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxelP Della Torre, A R Imondi, C Bernardi, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potentialP Della Torre, A Podestà, A R Imondi, et al.
Pageof 3